
Oncologist

No OPD information available
Neuroendocrine Tumor
Pulmonary Embolism
Appendix Cancer
B-Cell Lymphoma
Brain Tumor
Cerebral Hypoxia
Embryonal Tumor with Multilayered Rosettes
Folate Deficiency
Giant Cell Arteritis (GCA)
Glioma
Gliomatosis Cerebri
Juvenile Temporal Arteritis
Meningioma
Pancreatic Cancer
Pancreatic Islet Cell Tumor
Prostate Cancer
Prostatectomy
Temporal Arteritis
Thyroid Cancer
Thyroidectomy
Vasculitis
Paul J. Roach is a male healthcare provider who helps patients with different health issues like Neuroendocrine Tumor, Pulmonary Embolism, Appendix Cancer, and more. He is skilled in treating various conditions such as B-Cell Lymphoma, Brain Tumor, and Prostate Cancer.
Patients trust Paul J. Roach because he communicates effectively with them, explaining medical terms in a simple way. He listens to their concerns and provides clear guidance on treatment options. Patients appreciate his caring and compassionate approach.
To stay updated with the latest medical knowledge, Paul J. Roach regularly attends conferences and reads medical journals. He values continuing education to provide the best care for his patients.
Paul J. Roach works closely with other medical professionals, collaborating on patient care. He respects his colleagues and values teamwork in delivering comprehensive healthcare services.
Through his work, Paul J. Roach has positively impacted many patients' lives. His research on Gastroesophageal Neuroendocrine Tumors has been published in the Journal of Clinical Medicine. Additionally, his clinical trial on predicting radiotherapy response in rectal cancer has been completed, showing his commitment to advancing medical knowledge.
In summary, Paul J. Roach is a dedicated healthcare provider who uses his expertise to help patients with various health conditions. Patients trust him for his clear communication, up-to-date medical knowledge, and collaborative approach with colleagues. His research and clinical trials demonstrate his commitment to improving patient outcomes and advancing medical science.
Enrollment Status: Completed
Published: October 28, 2022
Intervention Type: Other
Study Drug:
Study Phase: Not Applicable
